Cited 0 times in Scipus Cited Count

Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity.

DC Field Value Language
dc.contributor.authorKim, SY-
dc.contributor.authorPark, JE-
dc.contributor.authorLee, YJ-
dc.contributor.authorSeo, HJ-
dc.contributor.authorSheen, SS-
dc.contributor.authorHahn, S-
dc.contributor.authorJang, BH-
dc.contributor.authorSon, HJ-
dc.date.accessioned2014-05-20T23:05:12Z-
dc.date.available2014-05-20T23:05:12Z-
dc.date.issued2013-
dc.identifier.issn0895-4356-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/10024-
dc.description.abstractOBJECTIVES: To develop and validate a new risk-of-bias tool for nonrandomized studies (NRSs).



STUDY DESIGN AND SETTING: We developed the Risk of Bias Assessment Tool for Nonrandomized Studies (RoBANS). A validation process with 39 NRSs examined the reliability (interrater agreement), validity (the degree of correlation between the overall assessments of RoBANS and Methodological Index for Nonrandomized Studies [MINORS], obtained by plotting the overall risk of bias relative to effect size and funding source), face validity with eight experts, and completion time for the RoBANS approach.



RESULTS: RoBANS contains six domains: the selection of participants, confounding variables, the measurement of exposure, the blinding of the outcome assessments, incomplete outcome data, and selective outcome reporting. The interrater agreement of the RoBANS tool except the measurement of exposure and selective outcome reporting domains ranged from fair to substantial. There was a moderate correlation between the overall risks of bias determined using RoBANS and MINORS. The observed differences in effect sizes and funding sources among the assessed studies were not correlated with the overall risk of bias in these studies. The mean time required to complete RoBANS was approximately 10 min. The external experts who were interviewed evaluated RoBANS as a "fair" assessment tool.



CONCLUSIONS: RoBANS shows moderate reliability, promising feasibility, and validity. The further refinement of this tool and larger validation studies are required.
-
dc.language.isoen-
dc.subject.MESHBias (Epidemiology)-
dc.subject.MESHClinical Trials as Topic-
dc.subject.MESHObserver Variation-
dc.subject.MESHQuality Assurance, Health Care-
dc.subject.MESHReproducibility of Results-
dc.subject.MESHRisk Assessment-
dc.subject.MESHStatistics as Topic-
dc.titleTesting a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity.-
dc.typeArticle-
dc.identifier.pmid23337781-
dc.identifier.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0895-4356(12)00322-8-
dc.contributor.affiliatedAuthor신, 승수-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.jclinepi.2012.09.016-
dc.citation.titleJournal of clinical epidemiology-
dc.citation.volume66-
dc.citation.number4-
dc.citation.date2013-
dc.citation.startPage408-
dc.citation.endPage414-
dc.identifier.bibliographicCitationJournal of clinical epidemiology, 66(4). : 408-414, 2013-
dc.identifier.eissn1878-5921-
dc.relation.journalidJ008954356-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pulmonary & Critical Care Medicine
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse